The researchers concluded that AOD9604 displayed a very good safety and tolerability profile indistinguishable from placebo. Critically, zero serious adverse events were attributed to the peptide, and no participants withdrew due to treatment-related effects
Ennour-Idrissi, K., Maunsell, E., & Diorio, C
Monitoring parameters during treatment should include regular assessment of therapeutic response, adverse effects, and relevant laboratory parameters
If you see white flecks, cloudiness, or a gel layer, do not inject
Do not place the vial in the freezer or near the cooling element at the back of the fridge, as freezing will destroy the medication
That can slow how the dose is used and is a known issue, particularly in women and larger patients where there is more tissue to pass through